OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Definitive urine drug testing in office-based opioid treatment: a literature review
Andrea G. Barthwell, Jeffrey T. Allgaier, Kenneth Egli
Critical Reviews in Toxicology (2018) Vol. 48, Iss. 10, pp. 815-838
Closed Access | Times Cited: 10

Showing 10 citing articles:

Direct-To-Definitive Urine and Oral Fluid Test Results for Unscreened and Rarely Screened Drugs in Individuals Applying for Methadone Treatment in 7 U.S. States
Miranda J. Lee-Easton, Stephen Magura, Ruqayyah Abu-Obaid, et al.
Journal of Psychoactive Drugs (2024), pp. 1-12
Closed Access | Times Cited: 2

Comparing presumptive with direct-to-definitive drug testing in oral fluid vs. urine for a U.S. national sample of individuals misusing drugs
Stephen Magura, Miranda J. Lee-Easton, Ruqayyah Abu-Obaid, et al.
Drug and Alcohol Dependence (2023) Vol. 250, pp. 110894-110894
Open Access | Times Cited: 6

Polysubstance Use Among Patients Treated With Buprenorphine From a National Urine Drug Test Database
Brendan Saloner, Penn Whitley, Leah LaRue, et al.
JAMA Network Open (2021) Vol. 4, Iss. 9, pp. e2123019-e2123019
Open Access | Times Cited: 12

Disposable 3D Printed Electrode for the Electrochemical Detection of Delta-9-Tetrahydrocannabinol in Aqueous Solution and 11-Nor-9-Carboxy-Tetrahydrocannabinol in Saliva
Érica Naomi Oiye, Maria Fernanda Muzetti Ribeiro, Bruno Ferreira, et al.
Brazilian Journal of Forensic Science Medical Law and Bioethics (2020) Vol. 9, Iss. 4, pp. 521-533
Open Access | Times Cited: 12

Intrauterine and Neonatal Exposure to Opioids: Toxicological, Clinical, and Medico-Legal Issues
Giuseppe Albano, Corinne La Spina, Walter Pitingaro, et al.
Toxics (2023) Vol. 11, Iss. 1, pp. 62-62
Open Access | Times Cited: 4

Evaluation of urine drug screen falsification of results among patients with opioid use disorder receiving treatment in a telehealth model of care
Rebekah Rollston, Barbara Burke, Scott G. Weiner, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 154, pp. 209151-209151
Closed Access | Times Cited: 4

Urine drug testing among Medicaid enrollees initiating buprenorphine treatment for opioid use disorder within 9 MODRN states
Lindsey R. Hammerslag, Jeffery Talbert, Julie M. Donohue, et al.
Drug and Alcohol Dependence (2023) Vol. 250, pp. 110875-110875
Open Access | Times Cited: 2

Detecting fraud, waste, and abuse in substance use disorder treatment
Melissa M. Garrido, David K. Jones, Alexander Woodruff, et al.
Health Services Research (2022) Vol. 57, Iss. 5, pp. 997-1000
Open Access | Times Cited: 4

Opioid Exposures Reported to U.S. Poison Centers
Saumitra V. Rege, Moira Smith, Heather A. Borek, et al.
Substance Use & Misuse (2021) Vol. 56, Iss. 8, pp. 1169-1181
Closed Access | Times Cited: 4

A benchmarking approach for characterizing providers’ patterns of treating patients with substance use disorder
Sivagaminathan Palani, Steven D. Pizer, Cecille Joan Avila, et al.
Healthcare Analytics (2023) Vol. 3, pp. 100134-100134
Open Access | Times Cited: 1

Page 1

Scroll to top